ABSTRACT
Transgenic plants present enormous potential as one of the most cost-effective and safe systems for large-scale production of proteins for industrial, pharmaceutical, veterinary and agricultural uses. Heat-stable plant-derived vaccines that are administered orally could in effect enhance vaccine coverage in children and infants, particularly in developing countries. Here we discuss the current status of plant-derived vaccines and their potential to champion the battle against infectious diseases in the least developed countries.
Similar content being viewed by others
REFERENCES
Thanavala Y, Huang Z, Mason HS. Plant-derived vaccines: a look back at the highlights and a view to the challenges on the road ahead. Expert Rev Vaccin. 2006;5(2):249–60.
McDonald KA, Hong LM, Trombly DM, Xie Q, Jackman AP. Production of human alpha-1-antitrypsin from transgenic rice cell culture in a membrane bioreactor. Biotechnol Prog. 2005;21(3):728–34.
Limaye A, Koya V, Samsam M, Daniell H. Receptor-mediated oral delivery of a bioencapsulated green fluorescent protein expressed in transgenic chloroplasts into the mouse circulatory system. FASEB J. 2006;20(7):959–61.
Bardor M, Cabrera G, Rudd PM, Dwek RA, Cremata JA, Lerouge P. Analytical strategies to investigate plant N-glycan profiles in the context of plant-made pharmaceuticals. Curr Opin Struct Biol. 2006;16(5):576–83.
Tacket CC. Plant based oral vaccines: results of human trials. Curr Top Microbiol Immunol. 2009;332:103–17.
Ko K, Koprowski H. Plant biopharming of monoclonal antibodies. Virus Res. 2005;111(1):93–100.
Villani ME, Morgun B, Brunetti P, Marusic C, Lombardi R, Pisoni I, et al. Plant pharming of a full-sized, tumour-targeting antibody using different expression strategies. Plant Biotechnol J. 2009;7(1):59–72.
Takagi H, Hirose S, Yasuda H, Takaiwa F. Biochemical safety evaluation of transgenic rice seeds expressing T cell epitopes of Japanese cedar pollen allergens. J Agric Food Chem. 2006;54(26):9901–5.
Smart V, Foster PS, Rothenberg ME, Higgins TJ, Hogan SP. A plant-based allergy vaccine suppresses experimental asthma via an IFN-gamma and CD4+CD45RBlow T cell-dependent mechanism. J Immunol. 2003;171(4):2116–26.
Beyer AJ, Wang K, Umble AN, Wolt JD, Cunnick JE. Low-dose exposure and immunogenicity of transgenic maize expressing the Escherichia coli heat-labile toxin B subunit. Environ Health Perspect. 2007;115(3):354–60.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hefferon, K.L. The Mucosal Immune Response to Plant-Derived Vaccines. Pharm Res 27, 2040–2042 (2010). https://doi.org/10.1007/s11095-010-0168-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-010-0168-9